Ian Dunn to Gene Expression Regulation, Neoplastic
This is a "connection" page, showing publications Ian Dunn has written about Gene Expression Regulation, Neoplastic.
Connection Strength
1.102
-
Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling. Cell Commun Signal. 2017 09 18; 15(1):34.
Score: 0.466
-
Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Sci Rep. 2021 09 09; 11(1):18009.
Score: 0.154
-
Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors. Endocrinology. 2017 07 01; 158(7):2284-2291.
Score: 0.115
-
Landscape of Genomic Alterations in Pituitary Adenomas. Clin Cancer Res. 2017 Apr 01; 23(7):1841-1851.
Score: 0.109
-
Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM. Proc Natl Acad Sci U S A. 2010 Jun 22; 107(25):11501-6.
Score: 0.070
-
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature. 2008 Sep 25; 455(7212):547-51.
Score: 0.062
-
Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell. 2007 Jun 15; 129(6):1065-79.
Score: 0.057
-
Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J Neurooncol. 2000 Oct-Nov; 50(1-2):121-37.
Score: 0.036
-
CK1epsilon is required for breast cancers dependent on beta-catenin activity. PLoS One. 2010 Feb 01; 5(2):e8979.
Score: 0.017
-
Genomics of human glioblastoma multiforme: a glimpse of the future. Neurosurgery. 2008 Dec; 63(6):15.
Score: 0.016